Anti-OLA1 autoantibody is a potential early diagnostic marker for hepatocellular carcinoma
Anti-OLA1 autoantibody shows promise as a serological HCC biomarker, with diagnostic performance significantly enhanced through combination with routine liver function parameters.
Authors
- Liping Dai
- Xiong Wen-zhuo (ORCID: https://orcid.org/0009-0004-8436-1862)
- Jianxiang Shi (ORCID: https://orcid.org/0000-0002-4346-3895)
- Hua Ye (ORCID: https://orcid.org/0000-0002-7568-7658)
- Keyan Wang (ORCID: https://orcid.org/0000-0002-7241-1656)
- Xuehui Duan (ORCID: https://orcid.org/0009-0008-7669-6768)
- Peng Wang (ORCID: https://orcid.org/0000-0003-3167-1547)
Institutions
- Zhengzhou University (CN)
- Zhengzhou University of Science and Technology (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-30
- DOI
- https://doi.org/10.3389/fimmu.2025.1647809
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00